专利名称：Liposomal mitigation of drug-induced
inhibition of the cardiac ikr channel
发明人：Lawrence Helson,George M. Shopp,Annie
Bouchard
申请号：US15403831申请日：20170111公开号：US10349884B2公开日：20190716
摘要：Compositions and methods are provided for preventing one or more cardiacchannelopathies or conditions resulting from irregularities or alterations in cardiacpatterns, or both, in a human or animal subject comprising: one or more
pharmacologically active agents that causes at least one of Ichannel inhibition or QTprolongation by inhibiting the activity of an ether-a-go-go-related gene (hERG); and oneor more liposomes, wherein the liposomes are empty liposomes and administered priorto, concomitantly, or after administration of the pharmacologically active agent.
申请人：SignPath Pharma Inc.
地址：Quakertown PA US
国籍：US
代理机构：Chalker Flores, LLP
代理人：Edwin S. Flores
更多信息请下载全文后查看
因篇幅问题不能全部显示，请点此查看更多更全内容